Dr. Vijay’s expertise lies in the management of all types of malignant and benign tumours and oncological emergencies.
He is well trained in conventional, 3DCRT, IMRT and IGRT based treatments, with a special interest in head and neck cancers, breast cancers and gynaecological cancers, brachytherapy (head & neck, breast, soft tissue sarcoma, cervix, vault), 3DCRT, IMRT, IGRT and palliative Care. He is also an expert in delivering intraluminal RT for esophagus cancer.
Training and Certifications
Dr. Vijay has completed his certification courses in clinical research methodology and cardiopulmonary resuscitation.
Dr. Vijay is also a recipient of various awards at both, international and national levels.
He has served as a sub-investigator for various clinical trials.
Dr. Vijay has presented his research at numerous national and international conferences.
Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients (2020). European journal of breast health, 16(1), 39.
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial (2019). Oncotarget, 10(54), 5605.
The predictive role of neutrophil-to-lymphocyte ratio in the outcomes of patients with sarcomatoid carcinoma of oral cavity (2021). European Archives of Oto-Rhino-Laryngology, 1-9.
Factors influencing non-adherence to radiotherapy: a retrospective audit of 1,548 patients from a tertiary cancer centre (2020). Journal of Radiotherapy in Practice, 19(4), 359-364.
Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience (2021). European Journal of Breast Health, 17(1), 62.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.